髂腔静脉支架置入后抗凝与抗血小板治疗评估:支架闭塞相关因素
中位随访19个月,三组一期通畅率分别为97.8%、85.7%和85.2%。支架直径对通畅率有显著影响,而抗凝持续时间似非显著因素。
要点
- 髂腔静脉支架置入后支架直径与通畅率显著相关。
- 抗凝治疗持续时间未显示与支架通畅率显著相关。
- 血栓后综合征和急性深静脉血栓患者支架闭塞及同侧DVT复发率较高。
核心结论
- 支架直径对髂腔静脉支架通畅率有显著影响。
- 抗凝治疗持续时间似乎不是支架通畅率的显著因素。
研究设计与样本
- 回顾性 review,纳入155例在大教学医院接受髂腔静脉静脉支架置入的患者。
- 记录临床与手术数据、抗凝或抗血小板治疗方式及持续时间以及结局。
主要发现
- 中位随访19个月(四分位距9-30个月)。
- 一期通畅率:May-Thurner综合征组97.8%,血栓后综合征组85.7%,急性深静脉血栓组85.2%。
- 支架再狭窄或闭塞:May-Thurner综合征组1例(2.2%),血栓后综合征组7例(14%),急性深静脉血栓组9例(15%)。
- 同侧DVT复发:血栓后综合征组7例(14%),急性深静脉血栓组15例(25%)。
临床怎么用
- 髂腔静脉支架置入时应关注支架直径选择,较大名义直径与更佳通畅率相关。
- 抗凝持续时间可能不是支架通畅的关键决定因素,需个体化评估。
局限性
- 回顾性研究设计。
- 样本量有限(155例)。
- 中位随访时间较短(19个月)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Iliocaval stenting has gained increased use over recent years for a variety of indications, including May-Thurner syndrome (MTS), post-thrombotic syndrome (PTS), and acute deep vein thrombosis (DVT). METHODS: A retrospective review of 155 patients undergoing iliocaval venous stenting at a large teaching hospital was performed. Clinical and procedural data, mode and duration of anticoagulation or antiplatelet therapy, and outcomes were recorded. RESULTS: Forty-five patients were treated for MTS, 49 for PTS. and 61 for acute DVT. The median follow-up was 19 months (interquartile range, 9-30 months). Primary patency rates were 97.8% in the MTS group, 85.7% in PTS, and 85.2% for the acute DVT group. Stent restenosis or occlusion occurred in one patient with MTS (2.2%), seven patients with PTS (14%), and nine patients with acute DVT (15%). An ipsilateral DVT recurred in 7 patients with PTS (14%) and 15 patients with acute DVT (25%). The stents that occluded had a tendency toward longer length (162.2 vs 125.2 mm; P = NS) and extension into the common femoral vein (18.8 vs 5.3%; P = NS). The patent stent group had statistically larger nominal diameter stents (P = .013). The duration of anticoagulation did not seem to be a significant factor in stent patency. CONCLUSIONS: Stent diameter has a significant influence on iliocaval stent patency rates.
引用
- Attaran RR, Ozdemir D, Lin IH, et al. Evaluation of anticoagulant and antiplatelet therapy after iliocaval stenting: Factors associated with stent occlusion. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 31203859. doi:10.1016/j.jvsv.2019.01.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。